Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error screen for the study record, replacing the expected content with a minimal header, navigation, and a Home button.SummaryDifference19%

- Check42 days agoChange DetectedRelated topics were added to the page, including Rheumatoid arthritis and a MedlinePlus Genetics entry. This expansion adds contextual disease terminology and links to genetics information on the study details page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page’s disease tagging and related resources were reduced by removing the 'Rheumatoid arthritis' topic and the 'MedlinePlus Genetics' related topics, altering the topic taxonomy and associated links.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the page's content or underlying system.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.